Yu Han

A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors

Jordi Rodón, Giuseppe Curigliano, Jean‐Pierre Delord et al. · Oncotarget · 2018 · 45 citations · Full text

LncRNA UCA1 mediates Cetuximab resistance in Colorectal Cancer via the MiR-495 and HGF/c-MET Pathways

Heng-heng Yuan, Xinchen Zhang, Xiaoli Wei et al. · Journal of Cancer · 2021 · 25 citations · Full text

Carbonylation of Runx2 at K176 by 4-Hydroxynonenal Accelerates Vascular Calcification

Xiaoxuan Zhai, Shengchuan Cao, Jiali Wang et al. · Circulation · 2024 · 25 citations

Evaluation of biomarker changes after administration of various neoadjuvant chemotherapies in breast cancer.

Guangchao Jin, Yu Han, Cun Liu et al. · PubMed · 2015 · 22 citations · Full text

Breast Oncology, Various Neoadjuvant Chemotherapies, Medicine +14

CX-5461 is a potent immunosuppressant which inhibits T cell-mediated alloimmunity via p53-DUSP5

Guopin Pan, Jing Zhang, Yu Han et al. · Pharmacological Research · 2022 · 16 citations · Full text

T-regulatory Cell, Immunology, Potent Immunosuppressant +7